| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 675,154 | 410,484 | 511,988 | 689,974 | | Cost of Revenue | 568,328 | 322,522 | 427,747 | 570,484 | | | Gross Profit | 106,826 | 87,962 | 84,241 | 119,490 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 38,919 | 36,768 | 42,356 | 36,844 | | Non Recurring |
-
|
-
| 343 | (418) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 67,907 | 51,194 | 41,542 | 83,064 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (39,099) | 915 | 1,283 | 883 | | Earnings Before Interest And Taxes | 69,096 | 52,109 | 42,825 | 83,947 | | Interest Expense | 32,776 | 24,968 | 23,137 | 24,033 | | Income Before Tax | 36,320 | 27,141 | 19,688 | 59,914 | | Income Tax Expense | (2,592) | 12,265 | (18,102) | 697 | | Minority Interest | (481) |
-
| (321) | (113) | | | | Net Income From Continuing Ops | (1,376) | 14,876 | 37,450 | 59,502 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| (16) | (40) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,857) | 14,876 | 37,434 | 59,462 | | Preferred Stock And Other Adjustments | 399 | (399) |
-
|
-
| | | Net Income Applicable To Common Shares | ($1,458) | $14,477 | $37,434 | $59,462 |
|
0.51% Nasdaq 
Income Statement
